Melda S. Dolan

436 total citations
9 papers, 313 citations indexed

About

Melda S. Dolan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Melda S. Dolan has authored 9 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Biomedical Engineering. Recurrent topics in Melda S. Dolan's work include Cardiac Imaging and Diagnostics (5 papers), Cardiac Valve Diseases and Treatments (3 papers) and Ultrasound in Clinical Applications (2 papers). Melda S. Dolan is often cited by papers focused on Cardiac Imaging and Diagnostics (5 papers), Cardiac Valve Diseases and Treatments (3 papers) and Ultrasound in Clinical Applications (2 papers). Melda S. Dolan collaborates with scholars based in United States, Belgium and India. Melda S. Dolan's co-authors include Arthur J. Labovitz, Michelle Bierig, David Cloutier, Sahar S. Abdelmoneim, Feng Xie, Sharon L. Mulvagh, Thomas R. Porter, Frank Aguirre, Ramón Castelló and Jeanette A. St. Vrain and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and American Heart Journal.

In The Last Decade

Melda S. Dolan

7 papers receiving 301 citations

Peers

Melda S. Dolan

RNMI

CCM

ONCOL

Alexander Ehlgen Germany

T. Krausz United Kingdom

Hang Zhao China

Christoph Artzner Germany

Arthur Filusch Germany

Cristina Sanina United States

Jin-Oh Choi South Korea

Yoshio Terasawa Japan

Ann Banke Denmark

Takenori Okada Japan

Alexander Ehlgen Germany

Melda S. Dolan

240 ×1.7

RNMI

56 ×0.4

CCM

140 ×1.3

9 ×0.2

ONCOL

28 ×0.5

Citations per year, relative to Melda S. Dolan Melda S. Dolan (= 1×) peers Alexander Ehlgen

Countries citing papers authored by Melda S. Dolan

Since Specialization

Citations

This map shows the geographic impact of Melda S. Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melda S. Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melda S. Dolan more than expected).

Fields of papers citing papers by Melda S. Dolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melda S. Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melda S. Dolan. The network helps show where Melda S. Dolan may publish in the future.

Co-authorship network of co-authors of Melda S. Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Melda S. Dolan. A scholar is included among the top collaborators of Melda S. Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melda S. Dolan. Melda S. Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Dolan, Melda S., et al.. (2025). Anti-tumor activity of CoREST inhibitor, JBI-802 (dual epigenetic modifier of LSD1/HDAC6): An opportunity to treat essential thrombocythemia and MPN/MDS patients with thrombocytosis in ongoing phase 1/2 clinical trial.. Journal of Clinical Oncology. 43(16_suppl).

Kovacs, Richard J., Giuliana Maldonado, Analía Azaro, et al.. (2014). Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study. Cardiovascular Toxicology. 15(4). 309–323. 81 indexed citations

Dolan, Melda S., Sahar S. Abdelmoneim, Feng Xie, et al.. (2008). Safety and Efficacy of Commercially Available Ultrasound Contrast Agents for Rest and Stress Echocardiography. Journal of the American College of Cardiology. 53(1). 32–38. 110 indexed citations

Dolan, Melda S., et al.. (2002). Does real-time perfusion have any incremental value for the sensitivity and specificity of dobutamine stress echocardiography?. Journal of the American College of Cardiology. 39. 350–350. 1 indexed citations

Dolan, Melda S.. (2001). For Left Ventricular Opacification and Endocardial Border Definition: is it Really Important Which Contrast Agent we Use, or is it the Imaging Modality we Choose?. European Journal of Echocardiography. 2(3). 154–162. 2 indexed citations

Dolan, Melda S., Sanjeev Puri, Kamala P. Tamirisa, et al.. (2001). Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. American Heart Journal. 142(5). 908–915. 78 indexed citations

Dolan, Melda S., Sanjeev Puri, Ramón Castelló, et al.. (1998). Prognostic significance of late-peaking left ventricular velocity contour in patients with aortic stenosis undergoing valve replacement. American Heart Journal. 136(1). 71–77.

Dolan, Melda S., et al.. (1998). Increasing the Dose and Rate of Albunex Infusion Leads to Superior Left Ventricular Contrast Effect. Journal of the American Society of Echocardiography. 11(5). 426–432. 6 indexed citations

Dolan, Melda S., Ramón Castelló, Jeanette A. St. Vrain, Frank Aguirre, & Arthur J. Labovitz. (1995). Quantitation of aortic regurgitation by Doppler echocardiography: A practical approach. American Heart Journal. 129(5). 1014–1020. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact